BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1766914)

  • 1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanism of action.
    Safe S; Astroff B; Harris M; Zacharewski T; Dickerson R; Romkes M; Biegel L
    Pharmacol Toxicol; 1991 Dec; 69(6):400-9. PubMed ID: 1766914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse Hepa 1c1c7 cells.
    Zacharewski T; Harris M; Safe S
    Biochem Pharmacol; 1991 Jun; 41(12):1931-9. PubMed ID: 1645554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: evidence for the role of the Ah receptor.
    Zacharewski T; Harris M; Biegel L; Morrison V; Merchant M; Safe S
    Toxicol Appl Pharmacol; 1992 Apr; 113(2):311-8. PubMed ID: 1313996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells.
    Krishnan V; Porter W; Santostefano M; Wang X; Safe S
    Mol Cell Biol; 1995 Dec; 15(12):6710-9. PubMed ID: 8524236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
    Merchant M; Morrison V; Santostefano M; Safe S
    Arch Biochem Biophys; 1992 Nov; 298(2):389-94. PubMed ID: 1329656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs.
    Nodland KI; Wormke M; Safe S
    Arch Biochem Biophys; 1997 Feb; 338(1):67-72. PubMed ID: 9015389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat.
    Astroff B; Safe S
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):435-43. PubMed ID: 2847362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells.
    Merchant M; Krishnan V; Safe S
    Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
    Harris M; Zacharewski T; Astroff B; Safe S
    Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonists: characterization of 6-[125I]methyl-8-iodo-1,3-dichlorodibenzofuran-Ah receptor complexes.
    Piskorska-Pliszczynska J; Astroff B; Zacharewski T; Harris M; Rosengren R; Morrison V; Safe L; Safe S
    Arch Biochem Biophys; 1991 Jan; 284(1):193-200. PubMed ID: 1846513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
    Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S
    Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8-trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct.
    Merchant M; Safe S
    Biochem Pharmacol; 1995 Aug; 50(5):663-8. PubMed ID: 7669069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone as antiestrogens in the female rat uterus.
    Romkes M; Safe S
    Toxicol Appl Pharmacol; 1988 Mar; 92(3):368-80. PubMed ID: 2832970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression.
    Zacharewski TR; Bondy KL; McDonell P; Wu ZF
    Cancer Res; 1994 May; 54(10):2707-13. PubMed ID: 8168101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 6-nitro-1,3,8-trichlorodibenzofuran as a partial estrogen in the female rat uterus.
    Dickerson R; Howie L; Safe S
    Toxicol Appl Pharmacol; 1992 Mar; 113(1):55-63. PubMed ID: 1313194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice.
    Bannister R; Biegel L; Davis D; Astroff B; Safe S
    Toxicology; 1989 Feb; 54(2):139-50. PubMed ID: 2922766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7.
    Fretland AJ; Safe S; Hankinson O
    Chem Biol Interact; 2004 Nov; 150(2):161-70. PubMed ID: 15535986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells.
    Harris M; Zacharewski T; Safe S
    Cancer Res; 1990 Jun; 50(12):3579-84. PubMed ID: 2340506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as an antiestrogen: effect on rat uterine peroxidase activity.
    Astroff B; Safe S
    Biochem Pharmacol; 1990 Feb; 39(3):485-8. PubMed ID: 2154986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells.
    Wang X; Porter W; Krishnan V; Narasimhan TR; Safe S
    Mol Cell Endocrinol; 1993 Oct; 96(1-2):159-66. PubMed ID: 8276131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.